Bowden Christopher

CIK 00016086014 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001608601

Recent Transactions

50 trades

Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-06-09+23,746→ 23,746 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2022-06-22+40,000→ 44,167 total
Award
Alaunos Therapeutics, Inc.$TCRT
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-18−1,885→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-18−46,608→ 992 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-18$60.11/sh−48,493→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-18$39.76/sh+1,885→ 17,372 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-18$50.40/sh+46,608→ 63,980 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-17−2,502→ 1,885 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-17$39.76/sh+2,502→ 17,989 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-17$60.02/sh−2,502→ 15,487 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-10$60.06/sh−20,853→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-10$39.76/sh+20,853→ 36,340 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-10−20,853→ 4,387 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-09−7,149→ 25,240 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-09$39.76/sh+7,149→ 22,636 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-09$60.16/sh−7,149→ 15,487 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-08$60.07/sh−6,675→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-08−6,675→ 32,389 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-08$39.76/sh+6,675→ 22,162 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-07$39.76/sh+4,268→ 19,755 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-06-07$60.04/sh−4,268→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-06-07−4,268→ 39,064 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-04-20$39.76/sh+1,888→ 29,888 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-04-20−12,513→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-04-20$35.16/sh+12,513→ 28,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-04-20$55.11/sh−14,401→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-04-20−1,888→ 43,332 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-04-19$55.16/sh−3,210→ 15,487 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-04-19−3,210→ 12,513 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-04-19$35.16/sh+3,210→ 18,697 total
Award
Alaunos Therapeutics, Inc.$TCRT
Stock Option (right to buy)
2021-03-04+31,250→ 31,250 total
Award
Alaunos Therapeutics, Inc.$TCRT
Common Stock
2021-03-04+4,167→ 4,167 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-02-24−986→ 15,410 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-02-22−3,334→ 3,333 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-02-22+3,334→ 16,396 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-02-16+2,750→ 15,131 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2021-02-16−2,750→ 0 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-02-16−2,069→ 13,062 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-02-14+4,000→ 12,381 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-02-14−4,000→ 8,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-02-10+11,000→ 11,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2021-02-10+44,000→ 44,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2020-05-21+24,000→ 24,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2020-05-20−3,583→ 15,723 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-05-20$35.16/sh+3,583→ 11,889 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-05-20$50.01/sh−3,583→ 8,306 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-14$40.64/sh−2,368→ 8,230 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-13+5,280→ 10,598 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2020-04-13−5,280→ 10,561 total

Companies

Recent Filings

Address

BICARA THERAPEUTICS INC. 116 HUNTINGTON AVENUE, SUITE 703

BOSTON, MA, 02116

View on SEC.gov